Genetic Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Fairfield Market Research's latest report on the Genetic Toxicology Testing market reveals a promising growth trajectory. The market is projected to expand at a CAGR of 15% from 2024 to 2031, reaching US$ 1.6 Bn by 2024 and US$ 4.2 Bn by 2031.

??????? ?? ?????? ??????

The growth of the Genetic Toxicology Testing market can be attributed to the increasing development and discovery of drugs, along with the rising use of pharmacogenomics. These factors are fueling the demand for genetic toxicology testing. Furthermore, the market has seen significant applications in sectors such as food, cosmetics, pharmaceuticals, and biotech, boosting the demand for genetic toxicology data. The ability to assess compounds that can induce genetic mutations or chromosomal damage is a key factor driving market growth. Additionally, the expansion of facilities and accessibility of funding worldwide are considerable growth determinants in the genetic toxicology testing industry.

?????????? ?????? ?????? ??? ?????? ???????

Between 2016 and 2021, the Genetic Toxicology Testing market grew at a CAGR of 9%. The adoption of genetic toxicology testing is set to rise, with the market expected to grow at a CAGR of 13% during the forecast period. By 2031, the market is anticipated to accumulate a value of US$ 4.56 Billion, driven by increasing drug development and the rising use of pharmacogenomics.

???????? ????????: ????? ??????? ?? ??? ?????????

North America leads the Genetic Toxicology Testing market, with significant contributions from the US. The region is projected to experience robust growth due to the increasing development of drugs and strong investments in pipelines. The presence of key players in North America facilitates the accessibility of genetic toxicology testing services for pharmaceutical and biotech companies. Additionally, the region benefits from high digital literacy and advanced infrastructure, promoting market growth.

?????????? ???????? ?? ????? ??? ?????? ????????????

The adoption of cloud and mobile technologies is accelerating the demand for genetic toxicology testing solutions. The market is witnessing increasing investments by key players to expand lab facilities, which enhances the accessibility and availability of these services. As the cloud becomes the standard for laboratory informatics software, service providers must implement cloud and SaaS strategies to remain competitive.

?????????? ????????????? ?? ??? ??????? ?????????? ??????? ??????

The COVID-19 pandemic has highlighted the importance of genetic toxicology testing, creating lucrative opportunities. While the pandemic had a devastating impact on society and economies, genetic toxicology testing played a neutral role in vaccine development. However, toxicity studies were crucial in understanding virus mutations, and numerous researchers used genotoxicology to assess drug effects against COVID-19.

?????????? ????? ?? ??? ??????? ?????????? ??????? ??????

Despite its growth potential, the Genetic Toxicology Testing market faces challenges, including the expensive nature of testing and the time required to obtain results. The cost of genetic testing ranges from under USD 100 to over USD 2,000, depending on the complexity of the test. Insurance coverage varies, and the lack of uniformity in terms of coverage and payout poses a challenge for market growth.

???????? ????????: ??????????? ?? ???? ????? ?????????? ?????????? ??????? ????? ?????

The ethical, scientific, and financial concerns associated with the use of animals in toxicology testing have accelerated interest in mechanistic in vitro testing approaches. For instance, a group of researchers in November 2021 assessed a testing strategy with in vitro techniques for genotoxicity, resulting in lower costs and faster results.

Key Market Players:

Thermo Fisher Scientific, Inc.
Charles River Laboratories International
Laboratory Corp of America Holdings
Eurofins Scientific
Jubilant Life Sciences Limited
Syngene International Limited
Gentronix Ltd.
Inotiv Inc.
Creative Bioarray
MB Research Laboratories

Market Segments Covered in Genetic Toxicology Testing Market Analysis:

Type

In Vitro
In Vivo

Product

Reagents & Consumables
Assays
Services

Application

Pharmaceutical & Biotechnology
Food Industry
Cosmetics Industry
Other

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global Genetic Toxicology Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Genetic Toxicology Testing Market Outlook, 2019 - 2031

3.1. Global Genetic Toxicology Testing Market Outlook, by Type, Value (US$ Bn), 2019 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. In Vitro
  - 3.1.1.2. In Vivo
3.2. Global Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Reagents & Consumables
  - 3.2.1.2. Assays
  - 3.2.1.3. Services
3.3. Global Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Pharmaceutical & Biotechnology
  - 3.3.1.2. Food Industry
  - 3.3.1.3. Cosmetics Industry
  - 3.3.1.4. Other
3.4. Global Genetic Toxicology Testing Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Genetic Toxicology Testing Market Outlook, 2019 - 2031

4.1. North America Genetic Toxicology Testing Market Outlook, by Type, Value (US$ Bn), 2019 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. In Vitro
  - 4.1.1.2. In Vivo
4.2. North America Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Reagents & Consumables
  - 4.2.1.2. Assays
  - 4.2.1.3. Services
4.3. North America Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Pharmaceutical & Biotechnology
  - 4.3.1.2. Food Industry
  - 4.3.1.3. Cosmetics Industry
  - 4.3.1.4. Other
4.4. North America Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 4.4.1.2. U.S. Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 4.4.1.3. U.S. Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 4.4.1.4. Canada Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 4.4.1.5. Canada Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 4.4.1.6. Canada Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
- 4.4.2. Market Attractiveness Analysis

5. Europe Genetic Toxicology Testing Market Outlook, 2019 - 2031

5.1. Europe Genetic Toxicology Testing Market Outlook, by Type, Value (US$ Bn), 2019 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. In Vitro
  - 5.1.1.2. In Vivo
5.2. Europe Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Reagents & Consumables
  - 5.2.1.2. Assays
  - 5.2.1.3. Services
5.3. Europe Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Pharmaceutical & Biotechnology
  - 5.3.1.2. Food Industry
  - 5.3.1.3. Cosmetics Industry
  - 5.3.1.4. Other
- 5.3.2. Market Attractiveness Analysis
5.4. Europe Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.2. Germany Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.3. Germany Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 5.4.1.4. U.K. Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.5. U.K. Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.6. U.K. Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 5.4.1.7. France Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.8. France Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.9. France Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 5.4.1.10. Italy Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.11. Italy Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.12. Italy Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 5.4.1.13. Turkey Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.14. Turkey Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.15. Turkey Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 5.4.1.16. Russia Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.17. Russia Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.18. Russia Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 5.4.1.19. Rest of Europe Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 5.4.1.20. Rest of Europe Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.21. Rest of Europe Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
- 5.4.2. Market Attractiveness Analysis

6. Asia Pacific Genetic Toxicology Testing Market Outlook, 2019 - 2031

6.1. Asia Pacific Genetic Toxicology Testing Market Outlook, by Type, Value (US$ Bn), 2019 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. In Vitro
  - 6.1.1.2. In Vivo
6.2. Asia Pacific Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Reagents & Consumables
  - 6.2.1.2. Assays
  - 6.2.1.3. Services
6.3. Asia Pacific Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Pharmaceutical & Biotechnology
  - 6.3.1.2. Food Industry
  - 6.3.1.3. Cosmetics Industry
  - 6.3.1.4. Other
- 6.3.2. Market Attractiveness Analysis
6.4. Asia Pacific Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 6.4.1.2. China Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.3. China Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 6.4.1.4. Japan Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 6.4.1.5. Japan Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.6. Japan Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 6.4.1.7. South Korea Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 6.4.1.8. South Korea Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.9. South Korea Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 6.4.1.10. India Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 6.4.1.11. India Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.12. India Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 6.4.1.13. Southeast Asia Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 6.4.1.14. Southeast Asia Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.15. Southeast Asia Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 6.4.1.16. Rest of Asia Pacific Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 6.4.1.17. Rest of Asia Pacific Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.18. Rest of Asia Pacific Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
- 6.4.2. Market Attractiveness Analysis

7. Latin America Genetic Toxicology Testing Market Outlook, 2019 - 2031

7.1. Latin America Genetic Toxicology Testing Market Outlook, by Type, Value (US$ Bn), 2019 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. In Vitro
  - 7.1.1.2. In Vivo
7.2. Latin America Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Reagents & Consumables
  - 7.2.1.2. Assays
  - 7.2.1.3. Services
7.3. Latin America Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Pharmaceutical & Biotechnology
  - 7.3.1.2. Food Industry
  - 7.3.1.3. Cosmetics Industry
  - 7.3.1.4. Other
- 7.3.2. Market Attractiveness Analysis
7.4. Latin America Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 7.4.1.2. Brazil Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.3. Brazil Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 7.4.1.4. Mexico Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 7.4.1.5. Mexico Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.6. Mexico Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 7.4.1.7. Argentina Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 7.4.1.8. Argentina Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.9. Argentina Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 7.4.1.10. Rest of Latin America Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 7.4.1.11. Rest of Latin America Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.12. Rest of Latin America Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
- 7.4.2. Market Attractiveness Analysis

8. Middle East & Africa Genetic Toxicology Testing Market Outlook, 2019 - 2031

8.1. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Type, Value (US$ Bn), 2019 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. In Vitro
  - 8.1.1.2. In Vivo
8.2. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Product, Value (US$ Bn), 2019 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Reagents & Consumables
  - 8.2.1.2. Assays
  - 8.2.1.3. Services
8.3. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Pharmaceutical & Biotechnology
  - 8.3.1.2. Food Industry
  - 8.3.1.3. Cosmetics Industry
  - 8.3.1.4. Other
- 8.3.2. Market Attractiveness Analysis
8.4. Middle East & Africa Genetic Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 8.4.1.2. GCC Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.3. GCC Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 8.4.1.4. South Africa Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 8.4.1.5. South Africa Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.6. South Africa Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 8.4.1.7. Egypt Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 8.4.1.8. Egypt Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.9. Egypt Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 8.4.1.10. Nigeria Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 8.4.1.11. Nigeria Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.12. Nigeria Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Genetic Toxicology Testing Market by Type, Value (US$ Bn), 2019 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Genetic Toxicology Testing Market by Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Genetic Toxicology Testing Market by Application, Value (US$ Bn), 2019 - 2031
- 8.4.2. Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Product vs By Application Heat map
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific, Inc
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Charles River Laboratories International
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Laboratory Corp of America Holdings
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Eurofins Scientific
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Jubilant Life Sciences Limited
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Syngene International Limited
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Gentronix Ltd.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Inotiv Inc.
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Creative Bioarray
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. MB Research Laboratories
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations